Table 1 MYO7A candidate variants for DFNA11 identified in this study.

From: The prevalence and clinical features of MYO7A-related hearing loss including DFNA11, DFNB2 and USH1B

Exon

Base change

AA Change

Domain

SIFT

PP2HV

MutTaster

MutAssessor

REVEL

CADD Phred

dbscSNV

TOMMO 38KJPN

gnomAD

exome

Pathogenicity

References

5

c.[420C>G;5503G>C]

p.[N140K;E1835Q]

Myosin head

D

P

D

L

0.415

20.3

0

0

Uncertain_Significance

This study

40

MyTH4 domain

T

B

D

L

0.593

13.9

0

0

5

c.[439C>T;1436T>C]

p.[R147C;L479P]

Myosin head

D

D

D

H

0.67

34.0

0

0.000008

Uncertain_Significance

This study

13

Myosin head

T

P

D

N

0.468

23.7

0

0

6

c.[479C>G;2947G>T]

p.[S160C;D983Y]

Myosin head

D

D

D

H

0.927

25.7

0

0

AD_Pathogenic

Iwasa YI et al., PLoS One. 2016;11:e016

24

D

B

D

M

0.573

28.2

0.000013

0

6

c.547T>C

p.S183P

Myosin head

D

D

D

M

0.858

26.5

0

0

Uncertain_Significance

This study

7

c.689C>T

p.A230V

Myosin head

D

D

D

M

0.818

35.0

0

0

AD_Pathogenic

Di Leva F et al., Audiol Neurootol. 2006;11:157–64

13

c.1436T>C

p.L479P

Myosin head

T

P

D

N

0.468

23.7

0

0

AD_Pathogenic

This study

17

c.1966C>G

p.L656V

Myosin head

D

D

D

M

0.788

26.8

0.000039

0

Uncertain_Significance

This study

17

c.1978G>A

p.G660R

Myosin head

D

D

D

H

0.976

32.0

0

0

AD_Pathogenic

Iwasa YI et al,. PLoS One. 2016;11:e016

17

c.2003G>A

p.R668H

Myosin head

D

D

D

H

0.886

34.0

0

0

AD_Likely_Pathogenic

Sang Q et al., PLoS One. 2013;8:e55178

18

c.2185A>G

p.K729E

Myosin head

D

P

D

H

0.926

24.5

0.0662

0

0

Uncertain_Significance

This study

21

c.2558G>A

p.R853H

IQ motif

D

D

D

M

0.741

34.0

0

0

AD_Likely_Pathogenic

Shearer AE et al., J Med Genet. 2013;50(9):627–34

21

c.2558G>T

p.R853L

IQ motif

D

P

D

H

0.619

34.0

0

0

Uncertain_Significance

This study

22

c.2600T>A

p.L867H

IQ motif

T

B

D

L

0.407

23.5

0.000039

0

Uncertain_Significance

This study

22

c.2651T>C

p.M884T

T

B

D

M

0.662

16.9

-

0

0

Uncertain_Significance

This study

22

c.2665G>A

p.A889T

T

B

D

M

0.475

23.4

-

0

0

Uncertain_Significance

This study

23

c.2708A>C

p.Q903P

T

B

D

L

0.682

24.1

-

0

0

Uncertain_Significance

This study

23

c.2717G>C

p.R906P

D

P

D

M

0.623

25.5

-

0

0

Uncertain_Significance

This study

23

c.2837_2839del

p.M946_F947delinsL

0

0

Uncertain_Significance

This study

23

c.2839T>G

p.F947V

D

D

D

M

0.845

28.2

0

0

Uncertain_Significance

This study

31

c.4118G>A

p.R1373Q

FERM domain

D

D

D

M

0.638

34.0

0.000040

0

Uncertain_Significance

This study

32

c.4157A>G

p.D1386G

FERM domain

D

B

D

M

0.433

25.2

0

0.000004

Uncertain_Significance

This study

37

c.5138C>T

p.T1713M

SH3 domain

D

D

D

M

0.747

34.0

0.000013

0.000019

Uncertain_Significance

This study

48

c.6529G>A

p.G2177R

FERM domain

D

D

D

M

0.751

34.0

0

0

Uncertain_Significance

This study

  1. All variants are indicated on NM_000260.
  2. AA, amino acid; PP2, PolyPhen2; MutTaster, mutation taster, MutAssessor, mutation assessor; D, deleterious (SIFT); T, tolerant (SIFT); D, probably damaging (PP2); P, possibly damaging (PP2); B, benign (PP2); D, disease-causing (MutTaster); N, polymorphism (MutTaster); H, high (MutAssessor); M, medium (MutAssessor); L, low (MutAssessor).